Sensorion Quote - ALSEN | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
Europe
EU
Sensorion (ALSEN) Share Price

Sensorion (ALSEN)

0.692

0.052

(8.12%)

Closed 01 December 3:30AM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

0.692

Bid

0.69

Offer

0.756

Volume

174,755

0.63 Day's Range 0.77

0.403 52 Week Range 1.04

Market Cap

Previous Close

0.64

Open

0.63

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

60,709

Shares Outstanding

300,250,225

Dividend Yield

-

PE Ratio

-9.39

Earnings Per Share (EPS)

-0.07

Revenue

5.7M

Net Profit

-22.06M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.sensorion-pharma.com

Headquarters

Montpellier, Herault, Fra

Founded

-

Sensorion is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALSEN. The last closing price for Sensorion was 0.64 €. Over the last year, Sensorion shares have traded in a share price range of 0.403 € to 1.04 €.

Sensorion currently has 300,250,225 shares in issue. The market capitalisation of Sensorion is 192.16 € million. Sensorion has a price to earnings ratio (PE ratio) of -9.39.

Sensorion Announces Its Participation in Upcoming Investor Conferences to be Held in November 2024

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within...

Sensorion annonce sa participation au 31ème Congrès annuel de la Société Européenne de Thérapie Génique et Cellulaire avec la présentation de plusieurs posters sur GJB2-GT

Regulatory News: Sensorion (FR0012596468 – ALSEN), société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et...

Sensorion Announces Webconference for Retail Shareholders on October 10, 2024

Sensorion to host a webconference dedicated to its retail shareholders on October 10, 2024, in French, at 6pm CET (12pm ET) Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering...

Sensorion Announces the Availability of its Half Year 2024 Report

Regulatory News: Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within...

Sensorion annonce de nouveaux résultats cliniques positifs présentés lors du Congrès Mondial d'Audiologie

Sensorion rapporte des données initiales de sécurité positives sur le premier patient injecté dans Audiogene, son essai clinique de thérapie génique en Phase 1/2 du SENS-501 Sensorion annonce...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.032	4.84848484848	0.66	0.77	0.584	39847	0.63140041	DE
4	-0.024	-3.35195530726	0.716	0.77	0.584	33239	0.67992118	DE
12	0	0	0.692	0.97	0.584	60709	0.79856446	DE
26	-0.092	-11.7346938776	0.784	0.97	0.57	42556	0.76027906	DE
52	0.162	30.5660377358	0.53	1.04	0.403	64542	0.72338513	DE
156	-1.036	-59.9537037037	1.728	2.29	0.26	76978	0.70488072	DE
260	-0.388	-35.9259259259	1.08	2.665	0.26	88624	1.09417213	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MLCOTCoretech 5	0.0175 € (75.00%)	11.13k
MLSRPSpeed Rabbit Pizza	6.30 € (20.00%)	5
ALTDTonner Drones	0.0116 € (18.37%)	45.26M
TRACTTeract SA	0.848 € (18.11%)	123.46k
ALVALValbiotis SA	1.40 € (18.04%)	613.41k
ALKALKALRAY SA	1.28 € (-40.74%)	637.99k
ALNEVNeovacs	0.0002 € (-33.33%)	16.21M
ALTAILighton	18.00 € (-24.37%)	173.99k
MLLOILocasystem International	12.50 € (-18.30%)	6
ALSAFSAFE	0.074 € (-17.41%)	178.68k
ALTDTonner Drones	0.0116 € (18.37%)	45.26M
BCPBanco Comercial Portugues SA	0.4478 € (0.22%)	38.08M
ATOAtos SE	0.8972 € (14.82%)	22.54M
ALHPIHopium SA	0.0089 € (-2.20%)	19.27M
ALNEVNeovacs	0.0002 € (-33.33%)	16.21M

ilovetech

ilovetech 4 minutes ago

Preliminary data from the subcutaneous trial showed an increase in mortality compared to IV administration. FDA will not approve with that finding.

skitahoe

skitahoe 4 minutes ago

ATL, while I love what you're saying about the potential of DCVax-L here, I suspect that we all know it will be cheaper in many countries, and probably more expensive here in the US, though the new administration may lessen what's paid here to support new drug development.

I believe t

SSKILLZ1

SSKILLZ1 5 minutes ago

Leaders in The Contest For Every Week

This chart will show who led for every week of the contest and how much they were up in the contest at the time. Hope this helps.
[pre]
Alias % Up
Week 1 NSOMNIYAK 10.67%
Week 2 NSOMNIYAK 18.80%
Week 3 MICK

1vman

1vman 5 minutes ago

*****🟥🟥🟥 Oh gosh oh gee ! Now I am hearing nonsense 80 BUCKS is possible for DBMM ??? not even a 🟥massive reverse split 🟥can get this OTC stinky pinky stock to those numbers

With no revenues ? little assets ? convertible debt ! SMH

karlacorn3

karlacorn3 5 minutes ago

Thanks. Hopefully the persistence yields a delivery. We're at one year from the original planned payout date. Fingers crossed.

K

SSKILLZ1

SSKILLZ1 6 minutes ago

Top Pick Stock Returns

Here is how every Top Pick picked in the contest is doing sorted by return so far. Hope this helps.
[pre]
Symbol % Move
1 OKLO 177.92%
2 PLTR 164.82%
3 OPTT 155.36%
4 GRRR 119.86%
5 TSLA 74.43%
6 CXD

delerious1

delerious1 6 minutes ago

What's not to like....all this in 3 months....

North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz/ton Silver, Sierra County, California
GlobeNewswire August 22, 2024

SSKILLZ1

SSKILLZ1 7 minutes ago

Individual Stock Returns

Here is how every stock picked in the contest is doing sorted by return so far. Hope this helps.
[pre]
Symbol % Move
1 AAOI 397.23%
2 PSIX 385.78%
3 SEZL 380.65%
4 APP 304.65%
5 TNZ.TO 296.15%
6 KI

SSKILLZ1

SSKILLZ1 8 minutes ago

Savvy Pick 10 Contest #1 Indexes

Commentary: We have numerous indexes to present this contest. So without further ado let me give a brief explanation of them. The The Top 27 Index is made up of all stock being picked at least 2 times in the contest, this index is equally weighted. The

OMOLIVES

OMOLIVES 9 minutes ago

I have been looking hard at Xerox for an entry. That statement in itself is insane....but need to throw small cash into something that can offset falling rates. Straight up thinking that said dividend will be cut in half so placing bet on 5% divi after. Just some where to throw $5k at most. I ha

Lykiri

Lykiri 10 minutes ago

U.S. pharmaceutical company Merck & Co is seeking to patent a new version of its blockbuster cancer immunotherapy, Keytruda, designed for subcutaneous injection rather than intravenous administration. This new formulation aims to extend the drug's market exclusivity and protect its multi-billion-dol

1vman

1vman 10 minutes ago

****🟥🟥🟥 GreenAcres Might be the place to be for 🚽HCWC🚽 , but a losing proposition for poor ole HCWC - With 5 little stores it will not do nothing to HCWCs bottom line - Wh👀ps !

https://www.youtube.com/watch?v=DrbPAt1_vc4

E

BIOChecker4

BIOChecker4 12 minutes ago

I’m simply urging newcomers to not be taken in by paid pumpers who look to take advantage of gullible investors. I see nothing wrong with that. I also urged newcomers to do their own due diligence and not take the word of any poster at face value. I added that if someone does their due diligence and

1vman

1vman 12 minutes ago

***** LOL ! 🚽HCMC🚽 4point plan ??? Notice near the bottom they indicate the following - just more OTC stinky pinky nonsense - Wh👀ps

In addition, when used in this release, the words “anticipates,” “believes,” “estimates,” “expects,” “int

dbergh

dbergh 13 minutes ago

Kamala Harris spent $1.5 billion on her failed presidential campaign, hemorrhaging on average $100 million per week — proving that she and her claque are as bad at managing money as they are at generating coherent policy ideas.

The big-ticket items:

$900,000 to adverti

againstallodds

againstallodds 13 minutes ago

Pretty obvious JarHead has to show GOLD

and not $12K / month paid for stupid PRs

Show us the Gold JarHead !!!

Stop kicking the can down the alley

https://investorshub.advfn.com/uimage/uploads/2023/5/19/kojss044E9F79-C962-4D00-A536-12BA3FE1C

janice shell

janice shell 13 minutes ago

Yes, it showed for me as embedded immediately. Twitter stuff is still messed up.

janice shell

janice shell 16 minutes ago

Hosai

Hosai 17 minutes ago

The EMA gives a short description of their justification for each approval/withdrawl/rejection. Here is a list of most of the rejections/withdrawls for this year (I may I missed a couple going by the stats of 8 withdrawn and 5 rejected so far but for whatever reason they don't seem to tally from wha

arizona1

arizona1 18 minutes ago

Is this coming through as embedded from bluesky? Because none of the twitter posts are coming through for me except for the url.

https://bsky.app/profile/cwebbonline.com/post/3lc7ii7pp4s2l

ChannelTrader

ChannelTrader 19 minutes ago

Watching closely.

SSKILLZ1

SSKILLZ1 21 minutes ago

OPTT Was the best performing stock pick today picked by NSOMNIYAK and the Best Top Pick was OPTT picked by NSOMNIYAK. hope this helps.

fuagf

fuagf 22 minutes ago

Lime Time, So you don't give a damn for democracy either. Not surprised you only care for your own creature comforts.

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions